| Trial Identifier: | D5680C00002 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03755934 |
| Start Date: | November 2018 |
| Primary Completion Date: | June 2023 |
| Study Completion Date: | June 2023 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Hungarian Translation | |
| Polish Translation | |
| Romanian Translation |
| Country | Location |
|---|---|
| DK | Gentofte, DK, 2820 |
| ES | Girona, ES, 17007 |
| ES | Valladolid, ES, 47003 |
| GB | Barnsley, GB, S75 3DL |
| GB | Blackpool, GB, FY2 0JH |
| GB | Cannock, GB, WS11 0BN |
| GB | CARDIFF, GB, CF14 4XW |
| GB | Leeds, GB, LS10 1DU |
| GB | London, GB, NW10 7EW |
| GB | Manchester, GB, M13 9NQ |
| GB | Prescot, GB, L34 1BH |
| GB | Stockton-on-Tees, GB, TS17 6EW |
| HU | Balatonfüred, HU, 8230 |
| HU | Budapest, HU, 1036 |
| HU | Budapest, HU, 1106 |
| HU | Győr, HU, 9024 |
| HU | Gyula, HU, 5700 |
| PL | Bydgoszcz, PL, 85-065 |
| PL | Gdańsk, PL, 80-382 |
| PL | Katowice, PL, 40-040 |
| PL | Katowice, PL, 40-282 |
| PL | Kraków, PL, 30-534 |
| PL | Lublin, PL, 20-093 |
| PL | Lublin, PL, 20064 |
| PL | Olsztyn, PL, 10117 |
| PL | Poznań, PL, 60-702 |
| PL | Rzeszow, PL, 35-302 |
| PL | Sochaczew, PL, 96-500 |
| PL | Toruń, PL, 87100 |
| PL | Warszawa, PL, 00-874 |
| PL | Warszawa, PL, 01144 |
| PL | Warszawa, PL, 01-192 |
| PL | Wrocław, PL, 53-413 |
| RO | Bucharest, RO, 020614 |
| RO | Bucuresti, RO, 022441 |
| RO | Bucuresti, RO, 020475 |
| RO | Bucuresti, RO, 011025 |
| RO | Calarasi, RO, 917080 |
| RO | Craiova, RO, 200505 |
| RO | Galati, RO, 800001 |
| RO | Galati, RO, 800291 |
| RO | Ploiesti, RO, 107400 |
| RO | Targu-Mures, RO, 540142 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company